Now that United States Anti-Doping Agency (USADA) has revealed that Ultimate Fighting Championship (UFC) light heavyweight champion Jon Jones failed his UFC 214 pre-fight drug test, questions are beginning to rise about the substance in question, Turinabol, and why it wasn’t detected in earlier screenings.
In fact, the situation doesn’t make any sense to California State Athletic Commission (CSAC) Executive Director Andy Foster, who was charged with regulating last month’s “Cormier vs. Jones 2” pay-per-view (PPV) event in Anaheim.
That said, he’s determined to get to the bottom of things and like opponent Daniel Cormier, isn’t ready to break “Bones” until the fact-finding process has been completed.
From his conversation with MMA Junkie:
“This entire situation doesn’t make any sense to me. It just doesn’t. If you’re doing a steroid panel, then this drug is going to show up every time. The fact that it didn’t show up on (July 6 and 7) when he was tested before, that’s an indication that he was not on that drug at that time. At that point, one of two things is probably going on here: He’s either extremely careless, or he’s a cheater. I know he’s already been extremely careless once in his career … but none of this makes any sense. That’s why I think it’s very important that we vet this and look at all the available evidence before we jump to conclusions and hang this guy out to dry.”
Too late for that in some circles.
Management insists Jones was felled by a tainted supplement, the same excuse used when the embattled pound-for-pound great came up dirty ahead prior to his attempted rematch against Cormier at UFC 200 last July.
Jones is still entitled to due process and likely won’t have the results of his B-sample until later this month, which is expected to be followed by (another) formal hearing. Until then, all we can do it wait.